Drugs that contain Cobicistat; Darunavir
1. Drug name - PREZCOBIX
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8518987 | JANSSEN PRODS | Pseudopolymorphic forms of a HIV protease inhibitor |
Feb, 2024
(1 year, 4 months from now) | |
| US7700645 | JANSSEN PRODS | Pseudopolymorphic forms of a HIV protease inhibitor |
Dec, 2026
(4 years from now) | |
| US8148374 | JANSSEN PRODS | Modulators of pharmacokinetic properties of therapeutics |
Sep, 2029
(6 years from now) | |
| CN101796040A | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2013
(9 years ago) | |
| CN100475819C | JANSSEN PRODS | A Pseudo-Polymorphic Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| CN1668623A | JANSSEN PRODS | A Pseudo-Polymorphic Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| CN101679325B | JANSSEN PRODS | Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent |
Jul, 2027
(4 years from now) | |
| CN103275033A | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN103435570A | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN101490023B | JANSSEN PRODS | Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent |
Jul, 2027
(4 years from now) | |
| CN101490023A | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN103275033B | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN103435570B | JANSSEN PRODS | Pharmacokinetics Character Regulator Of Therapeutic Agent |
Jul, 2027
(4 years from now) | |
| CN101679325A | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| IN332719B | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| IN200810487P1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP1567529A2 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP1567529B2 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP2767539B1 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP2314591B1 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP3045460B1 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP2314591A1 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP2314591B2 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP3045460A1 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP1567529B1 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP2767539A1 | JANSSEN PRODS | Pseudopolymorphic Forms Of A Hiv Protease Inhibitor |
May, 2023
(7 months from now) | |
| EP3112355A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2487165B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2487165A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP3112355B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2049506A2 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2049506B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2049506B9 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2487161B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2118082A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2118082B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487161A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP3150586B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP3150586A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487166A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487166B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487162A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487162B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487163A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Mar, 2028
(5 years from now) | |
| EP2487163B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Mar, 2028
(5 years from now) | |
| EP2170851B1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2028
(5 years from now) | |
| EP2170851A1 | JANSSEN PRODS | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2028
(5 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US8518987
(Pediatric) | JANSSEN PRODS | Pseudopolymorphic forms of a HIV protease inhibitor |
Aug, 2024
(1 year, 10 months from now) | |
|
US7700645
(Pediatric) | JANSSEN PRODS | Pseudopolymorphic forms of a HIV protease inhibitor |
Jun, 2027
(4 years from now) | |
| US10039718 | JANSSEN PRODS | Use of solid carrier particles to improve the processability of a pharmaceutical agent |
Oct, 2032
(10 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 150MG;800MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.